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Abstract 
Background: We present a case of a combined hamartoma of the retina and retinal pigment epithelium associated 
with a subfoveal acquired vitelliform lesion induced by vitreomacular traction. The purpose of this report is to present 
a unifying hypothesis of these concurrent findings, as aided by multimodal imaging.
Case Presentation: A 25‑year‑old white man presented with a 6‑month history of a visual disturbance in his left eye. 
At presentation, ophthalmic assessment showed a combined hamartoma adjacent to his optic nerve that had caused 
marked corrugation within the inner retinal surface. An acquired vitelliform lesion was present in the macula with an 
associated epiretinal membrane as demonstrated on spectral‑domain optical coherence tomography. Optical coher‑
ence tomography angiography corroborated the clinical diagnosis of combined hamartoma.
Conclusions: We are not aware of previous cases of a combined hamartoma associated with an acquired vitelliform 
lesion. As previously proposed in acquired vitelliform lesions related to epiretinal membrane and vitreoretinal traction, 
we believe that macular tractional forces might interfere with retinal pigment epithelium phagocytosis of shed outer 
segments, leading to the occurrence of this acquired vitelliform lesion.
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Background
Combined hamartoma of the retina and retinal pig-
ment epithelium (henceforth referred to as combined 
hamartoma) was first described by Gass, in 1973, as an 
uncommon tumor in a series of seven patients [1]. He 
characterized these intraocular tumors in terms of thick-
ened retinal tissue with a hyperpigmented tumor base 
and often presenting with contractions at the inner reti-
nal surface [1]. He also concluded that they were con-
genital. Hisopathologically, combined hamartomas have 
been described as conglomerations of disorganized reti-
nal, glial and vascular tissue intertwined with tubules 
of retinal pigment epithelium (RPE) with reduplication 
of the normally singular RPE layer [2, 3]. Several case 
reports have documented the association of these lesions 
with concurrent intraocular or systemic comorbidities 
such as neurofibromatosis types II and I [4–6], branchio-
oculofacial syndrome [7], Gorlin-Goltz syndrome [8], 
Poland abnormality [9] and juvenile nasopharyngeal ang-
iofibroma [10].
In the largest studied series of combined hamartomas 
(79 eyes from a single institution) Shields et al. found that 
common clinical characteristics included intralesional 
corkscrew vessels (65  %), retinal traction (81  %), and 
epiretinal membrane (61  %) [11]. According to Shields 
Open Access
*Correspondence:  kbfnyf@aol.com 
1 Vitreous‑Retina‑Macula Consultants of New York, 460 Park Avenue, Fifth 
Floor, New York 10022, NY, USA
Full list of author information is available at the end of the article
Page 2 of 6Chae et al. Int J Retin Vitr  (2015) 1:23 
et  al., the time-domain optical coherence tomography 
findings of combined hamartomas were most notable for 
dense epiretinal membranes leading to significant vitreo-
retinal traction with eventual retinal thickening and dis-
organization over the tumor itself [12]. Novel imaging 
techniques such as spectral-domain optical coherence 
tomography (SD-OCT) have allowed for better deline-
ation of tumor tissue composition over the vitreoretinal 
interface. For instance, using enhanced depth imaging 
optic coherence tomography, Arepalli et al. described the 
presence of epiretinal membrane with traction in a saw-
tooth or folded pattern at the vitreoretinal interface [13]. 
While epiretinal membranes are known to occur com-
monly with combined hamartomas, we report a unique 
presentation of a combined hamartoma concurring with 
an acquired vitelliform lesion (AVL) in the macula, sec-
ondary to tractional forces. We further describe the 
intrinsic vascular pattern of a combined hamartoma using 
optical coherence tomography angiography (OCTA).
Case presentation
A healthy 25-year-old white male presented complaining 
of a gradual and progressive visual disturbance in his left 
eye for 6 months. His Snellen best corrected visual acuity 
was 20/20 in each eye and the anterior segment exami-
nation was unremarkable bilaterally. Dilated fundoscopy 
of the right eye was normal; fundoscopy of the left eye 
showed a slightly elevated greyish lesion with scattered 
pigmentary changes superior to the optic nerve which 
extended in a fan-like distribution from the optic nerve 
(Fig.  1). There were tortuous fine retinal vessels overly-
ing the lesion with radial retinal folds that appeared to be 
emanating from the infero-temporal aspect of the lesion. 
The folds extended into the macula and a small intrareti-
nal hemorrhage was noted at the superior macula along 
with a vitelliform lesion near the fovea.
SD-OCT through the tumor showed thickening and 
disorganization of the inner and outer retina with marked 
saw-tooth like corrugations along the vitreoretinal inter-
face (Fig.  1). The subfoveal vitelliform lesion appeared 
hyperreflective with preservation of the external limiting 
membrane and ellipsoid layer at the site of the lesion. SD-
OCT also revealed the presence of an epiretinal mem-
brane with contraction of the inner retinal layers of the 
macula.
Fundus autofluorescence showed intense hyperauto-
fluorescence from the vitelliform lesion as well as granu-
lar hypoautofluorescence inferotemporal to the lesion 
Fig. 1 Color fundus photograph of the left eye in a 25‑year‑old man with a combined hamartoma, with magnified insets and accompanying hori‑
zontal cross sectional spectral domain optical coherence tomography (SD‑OCT) images. A subfoveal vitelliform lesion is noted (yellow arrow)
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(Fig.  2). A linear masking of the background autofluo-
rescence was visible in the area of the intraretinal hem-
orrhage. While retinal autofluorescence was obscured at 
the superior optic nerve head margin, a notable, large, 
speckled pattern of hypoautofluorescence was visible 
surrounding the optic disc and extending well beyond the 
clinically visible boundaries of the lesion along its entire 
perimeter. Early hyperfluorescence of the combined 
hamartoma was visible in fluorescein angiography along 
with an increased intrinsic vascularity within the lesion 
itself (Fig. 2).
OCTA revealed significant distortion of the retinal 
microcirculation intralesionally along the radial peripap-
illary capillary network superior and superotemporally 
to the optic nerve head with vessels appearing fine and 
tortuous in a corkscrew pattern (Fig. 3). Surrounding this 
network of corkscrew vessels were straight radial vessels 
normally found in a physiological peripapillary capillary 
network.
Similar to the description of combined hamartomas 
by Gass in 1973 [1], our patient presented with a unilat-
eral grey lesion that was slightly elevated, involving the 
RPE, retina and the overlying vitreous which extended in 
a fan-like projection towards the periphery and blended 
imperceptibly with the surrounding tissue. After the 
initial identification of combined hamartomas by Gass, 
many other studies have documented common manifes-
tations observed with these tumors, including a study by 
Shields et al. [4]. In a similar study of 60 patients, com-
bined hamartomas are described as having vascular tor-
tuosity (93  %), pigmentation (87  %), elevation (80  %), 
vitreoretinal interface disturbances (78 %), and lipid exu-
dation (7 %) [14].
These observed clinical characteristics are confirmed 
and further elaborated with the aid of multimodal imag-
ing, including novel techniques such as OCTA, which 
allowed for depiction of the tumor’s vasculature without 
the need for intravenous dye injection and without the 
limits in resolution arising from extravasation of fluores-
cein dye [15]. OCTA confirms and topographically maps 
out the increased and seemingly disorganized vascula-
ture in the tumor as previously described [3, 14]. While 
the presence of thickened glial and retinal tissue makes it 
difficult to view the vascular architecture on fundoscopic 
Fig. 2 Multimodal imaging of the left eye of a 25‑year‑old man with a combined hamartoma and subfoveal vitelliform lesion. Fluorescein angiog‑
raphy shows distortion of the peripapillary vasculature while demonstrating the microcirculation within the hamartoma. Red‑free imaging shows 
the  extent of tangential traction with radial striae emanating from the tumor, which involves the fovea. Fundus autofluorescence shows speckled 
pattern of hypoautofluorescence due to the masking effect of the hamartoma. The subfoveal vitelliform lesion is intensely hyperautofluorescent
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examination, OCTA isolates and enables clear visualiza-
tion of the vascular network.
Our patient manifested many of the characteristics 
mentioned above. However, he presented uniquely with 
a subfoveal acquired vitelliform lesion in the setting of 
traction occurring at the vitreoretinal interface. Acquired 
vitelliform lesions are known to occur in tractional mac-
ulopathies in which significant vitreomacular traction is 
present [16, 17]. For instance, in a study of 87 patients 
with unilateral epiretinal membrane, a subfoveal vitelli-
form lesion was found in 15 patients (17.2 %) compared 
to only 5 patients (5.7 %) in matched control fellow eyes 
(p = 0.03) [17]. According to Freund et al., normal appo-
sition between the photoreceptor tips and the RPE is 
disrupted by tractional forces which can interfere with 
phagocytosis of shed outer segments in the RPE [16]. 
Subsequent accumulation of lipid-laden macrophages 
and RPE cells may account for the yellow vitelliform col-
lection which appears hyperreflective on SD-OCT [16]. 
The common natural progression of AVLs is gradual 
absorption of the lesion with subsequent atrophy or, in 
rare cases, formation of a macular hole; both scenarios 
lead to poor visual outcomes [18–20].
A combined hamartoma can cause visual impairment 
in several ways, but vision loss most commonly occurs 
when retinal dragging causes foveal distortion [11, 14, 
21]. When significant visual impairment is observed sec-
ondary to fovea-involving traction, treatment options 
include surgery to relieve the vitreomacular tractional 
component. Surgical management, however, remains 
controversial, as previous reports documenting visual 
improvement following vitrectomy and membrane peel-
ing are anecdotal [22–25]. While combined hamartoma 
is a benign tumor, macular edema and choroidal neo-
vascularization (CNV) can occur in association with 
these lesions, which can lead to a poor visual outcome 
[26]. Treatment of CNV in the past has included photo-
dynamic therapy and laser photocoagulation but, more 
recently, intravitreal antiangiogenic injections have been 
utilized [27, 28].
Conclusion
Diffuse retinal folds seen emanating from the tumor and 
extending over the macula indicate the presence of sig-
nificant macular contraction where the subfoveal vitelli-
form lesion lies. SD-OCT served as a diagnostic adjunct 
to further localize the area of traction occurring along 
the vitreoretinal interface as evidenced by the presence 
inner retinal corrugations with an overlying epiretinal 
membrane. AVLs have been noted to occur in tractional 
maculopathies caused by epiretinal membranes, and we 
believe that the tractional forces described above resulted 
in the formation of an AVL in our patient. We addition-
ally attribute the epiretinal gliosis and subsequent trac-
tion on the inner retinal vessels to have caused the linear 
retinal hemorrhage seen in the superior macula.
Both combined hamartomas and AVLs are capable of 
compromising vision if the integrity of the ellipsoid is 
compromised, either through direct traction or due to 
late outer retinal changes often seen in acquired vitelli-
form lesions. Despite the significant retinal striations and 
contraction seen in our patient, his foveal architecture 
remained generally undisturbed with relative sparing of 
the outer retinal landmarks accounting for his preserved 
visual acuity. Furthermore, as our patient did not exhibit 
any evidence of edema or CNV in association with the 
combined hamartoma, there was no rationale for the use 
of anti-inflammatory agents or antiangiogenic injections. 
Given these findings and the lack of consistent favorable 
outcomes after surgical intervention, close observation 
was recommended to the patient.
In summary, the advent of novel imaging modali-
ties including SD-OCT has allowed for detailed charac-
terization of combined hamartomas, particularly at the 
vitreoretinal interface. We are not aware of previously 
published OCTA imaging of combined hamartomas, 
which, in our patient, revealed features of the tumor’s 
microvascular morphology hitherto only seen in histo-
pathological studies.
Fig. 3 En‑face optical coherence tomography angiography (OCTA) 
montage of the left eye of a 25 year old man with a combined hamar‑
toma and subfoveal vitelliform lesion incorporating a 4.5 × 4.5 mm 
scan of the peripapillary area, a 6 × 6 mm scan of the macula, and a 
higher resolution 3 × 3 mm scan of the fovea. Segmentation of all 
scans includes the full thickness of the neurosensory retina. The flow 
signature corresponding with the small vessels of the hamartoma has 
a disorganized morphology. Tractional effects and distortion of the 
foveal avascular zone are also appreciated
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Consent
Written informed consent was obtained from the patient 
for publication of this Case report and any accompanying 
images.
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